Skip to main content
Home
Home

Meta navigation

  • Contact
  • Donate
  • Jobs

Main navigation

  • For patients
  • For researchers
  • About us
  • Network

Lymphoma

5 currently open clinical trials
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Randomized phase II trial on fitness- and comorbidity- tailored treatment in elderly patients with newly diagnosed Primary CNS Lymphoma
IELSG-45
Phase II study of combination ibrutinib and rituximab in untreated marginal zone lymphomas
IELSG-47
Alternative chemotherapy regimen for patients with Hodgkin lymphoma
HD 21
Optimization of chemotherapy for Burkitt lymphoma
HOVON 127/ SAKK 37/16
All cancer types

Footer

Footer main navigation

  • For patients
  • For researchers
  • About us
  • Network

Footer Quicklinks

  • Trials
  • Events
  • News
  • Portal

Footer meta navigation

  • Contact
  • Donate
  • Jobs
Newsletter subscription

Follow us on

  • EN
  • DE
  • FR

© 2018 SAKK - Swiss Group for Clinical Cancer Research, Effingerstrasse 33, 3008 Bern - Switzerland

Footer navigation

  • Imprint

Mobile main navigation

  • For patients
    • For patients
    • Participate in a trial
    • Genetic Counseling
    • FAQ
    • Glossary
    • Downloads
  • For researchers
    • For researchers
    • Research groups
    • Young Oncology Academy
    • Grants and fellowships
    • Electronic Data Capture (EDC)
  • About us
    • About us
    • Mission statement
    • Organization
    • Board and Executive Board
    • Patient Advisory Board
    • Support and collaborations
    • Media and publications
  • Network

Mobile meta navigation

  • Contact
  • Donate
  • Jobs
    • Vacancies
    • Work for us
    • Our values
    • Work–life balance
    • Wages and benefits
    • Staff development

Mobile footer navigation

  • Imprint
  • EN
  • DE
  • FR

Mobile quicklinks

  • Trials
  • Events
  • News
  • Portal

Quicklinks

  • Trials
  • Events
  • News
  • Portal